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Cell  surface  antigens  of the  thymus-leukemia  (TL) 1 system  in  the  mouse  are 
detectable only on thymocytes and cells of certain leukemias {1-3). Although TL 
antigens  are  not  expressed  on  thymocytes  of  all  mouse  strains,  leukemias 
developing  in  TL-  strains  may  be  phenotypically  TL+,  suggesting  that  TL 
structural  genes may be present in all mouse strains, and possibly in all cells (2). 
The  appearance  of TL antigens  on thymocytes and leukemia cells presumably 
results from  activation  or de-repression  of these structural  genes by regulatory 
genes  (4). 
Initial  attempts to immunize TL-  mice against their own TL+ leukemias by 
making  them  hyperimmune  to  TL  antigens  were  unsuccessful,  and  when 
leukemia cells were recovered from these mice they had become phenotypically 
TL-  (1). The cells remained TL-  as long as they were passaged continually in 
hyperimmune  mice,  but  regained  the  TL+  phenotype  when  returned  to 
nonimmunized  mice.  This  reversible  loss  of TL antigenicity  has  been  termed 
antigenic modulation, and occurs rapidly when cells are exposed to TL antiserum 
either  in  vivo  (1,  5)  or  in  vitro  at  37°C  (6),  cell  surface  an'tigenicity  being 
measured by the cytotoxic activity of a subsequent exposure of cells to fresh TL 
antiserum  in the presence of lytic complement  (C'). 
Analysis  of antigenic  modulation  in  vitro  suggested  to  Old  et  al.  (6)  that 
modulated TL antigen-antibody  complexes were lost from the cell surface by a 
process  requiring  cellular  metabolic  activity.  Loss  of these  complexes  could 
presumably occur either by exfoliation from the cell surface or internalization  by 
pinocytosis. Yu and Cohen  (7)  have suggested that pinocytosis may account for 
the apparent  loss of modulated TL antigens. 
Although  antigenic  modulation  has  not  been  demonstrated  in  the  same 
* Supported in part by National Cancer Institute grant CA-08748. 
1Abbreviations used in this paper: C', complement; FBS, fetal bovine serum; FITC,  fluorescein 
isothiocyanate;  FTC,  fluoresceinyl  thioureido  caproic  acid;  NMS,  normal  mouse  serum;  PBS, 
phosphate-buffered saline; SBMV, southern bean mosaic virus; TL, thymus leukemia. 
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manner  for  other  surface  antigens  on  mouse  lymphoid  cells,  H-2  antigens  on 
leukemia  cells  have  been  modulated  with  a  combination  of H-2  antibody  and 
antimouse  immunoglobulin  (Ig)  antibody  (8,  9),  while  surface  Ig  on  mouse 
myeloma  cells  has  been  modulated  directly  with  anti-Ig  antibody  (8).  In  both 
cases,  pinocytosis  of  cell-bound  antibody  complexes  was  considered  the  most 
likely explanation  for  modulation. 
We  have  examined  modulation  of TL  antigenicity  from  mouse  leukemia  cells 
and  thymocytes  by  cytotoxicity,  immunofluorescence,  and  immunoelectronmi- 
croscopy,  and  have  found  that  most  modulated  TL  antigen-antibody  complexes 
remain  on  the  cell  surface,  displaced  topographically  into  aggregates  or "caps" 
(10),  while  a  smaller  proportion  is  internalized  by  pinocytosis. 
Materials and Methods 
Mice.  These were obtained from our colonies and included strains A (phenotype TL. 1,2,3; H-2  ~) 
and C57BL/6 (TL-; H-2'), and the congenic stocks, A/TL- (TL  ; H-2~), C57BL/6/TL+ (TL. 1,2,3; 
H-2b),  and C57BL/6/H-2  ~ (TL-; H-2~). 
Mouse  Alloantisera.  Two  mouse  alloantisera  specific  for  TL.1,2,3  antigens,  (A/TL-  × 
C57BL/6)F1 anti-A strain spontaneous leukemia ASL1 (anti-ASL1) and A/TL  anti-A strain thymus 
(antithymus)  were  used.  Antithymus  antiserum  was  used  in  experiments  in  which  absolute 
specificity to TL. 1,2,3 antigens was critical, since anti-ASL1 antiserum might occasionally contain 
leukemia-specific antibodies  (11)  or antibodies  to C-type viruses present  in ASL1 cells (T.  Aoki, 
personal communication) which might cross-react with viruses at the surfaces of leukemia cells used 
as test cells in these experiments.  Both antisera  were absorbed twice with (A/TL-  x  C57BL/6)F1 
thymus cells to remove autoantibodies (12) and absorbed twice with C57BL/6/TL+ or (A x  C57BL/6/ 
TL+)F~  spleen ceils to eliminate possible H-2-related histocompatibility antibodies not detectable 
by cytotoxicity (13). After absorption, both antisera were tested on a variety of cell types by the cyto- 
toxicity test and by indirect immunofluorescence, and were found to be highly specific for TL. 1, 2, 3 
antigens.  An alloantiserum specific for H-2  b antigens was prepared  by immunizing (C57BL/6/H-2  ~ 
x  A)F~ mice with the C57BL ascites leukemia EL4,  while an anti-H-2  ~ alloantiserum was prepared 
by immunizing C57BL/6 mice with the BALB/c ascites tumor Meth A. 
Rabbit Antisera.  Rabbits were immunized with mouse IgG or Fc fragments of mouse IgG purified 
according to H~immerling and Rajewsky (14). 
Fractionation of A~tisera.  (a) The IgG fraction of rabbit antimouse IgG antiserum was obtained 
by  precipitation  with  40%  ammonium  sulfate  and  chromatography  on  a  diethylaminoethyl 
(DEAE)-Sephadex A-50 column,  and  concentrated  by diaflo filtration  (Amicon Corp.,  Lexington, 
Mass.). F(ab')2 fragments were prepared by pepsin digestion of this IgG fraction, and were purified 
specifically with immunoadsorbents  (15).  (b) Fab' fragments of anti-ASL1 antiserum were prepared 
according to Lamm et al.  (16),  except that  initial fractionation of the antiserum  was achieved by 
precipitation with 40% ammonium sulfate. These preparations  were shown to be essentially free of 
intact bivalent antibody by immunodiffusion (15). 
Fluoresceination  of  Antisera.  Purified  IgG  fractions  of  rabbit  antisera  were  conjugated  to 
fluorescein  isothiocyanate  (FITC)  by  the  method  of  Cebra  and  Goldstein  (17).  The  molar 
fluorescein : protein ratio of rabbit antimouse IgG/FITC antibody was  1.8,  while the ratio of rabbit 
antimouse  Fc  fragments/FITC  antibody  was  2.6.  A  crude  IgG fraction  of anti-ASL1  antiserum, 
obtained  by precipitation with 40% ammonium sulfate, was conjugated to fluoresceinyl thioureido 
caproic  acid  (FTC)  by  reaction  with  a  water-soluble  carbodiimide  derivative  (18).  The  molar 
fluorescein : protein ratio of this conjugate was 0.6. 
Procedure for Modulation In Vitro. The radiation-induced A strain leukemia RADA1 (TL. 1, 2, 3; 
H-2~),  in aseites  form,  and  thymocytes from the  congenic mouse stock C57BL/6/TL+  (TL.  1,2,3; 
H-2  ~)  were used as test ceils.  Cell suspensions  in medium  199 containing 2% gamma globulin-free 
fetal bovine serum (FBS; Grand Island Biological Co.,  Grand Island, N. Y.) were washed twice and 
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mincing thymus tissue with scissors in a few drops of medium and collecting the supernate. Only cell 
suspensions with greater than 90% viability were used in these experiments. For modulation, 5 ×  10 e 
cells were  suspended  in  i  ml of medium  containing  2%  FBS  and  antiserum  in  the  appropriate 
concentration,  in a  glass centrifuge tube.  It was found unnecessary to incubate cells under tissue 
culture conditions, since the incubation medium remained close to its initial value of pH 7.4 when 
cells were maintained in a water bath-shaker at 37 °C for more than 4 h. The tubes were also manually 
shaken every 5 min to insure that  all cells remained freely suspended.  For controls, antiserum was 
omitted  or  replaced  with  pooled  normal  mouse  serum  (NMS).  After the  appropriate  length  of 
incubation, cells were immediately cooled in an ice bath and washed twice in the cold. 
Cytotoxicity  Test  (19, 20). Cells  (0.05  ml  of a  suspension  containing  5  ×  106  cells/ml)  were 
incubated with 0.05 ml of serial dilutions (1/100 to 1/100,000)  of antiserum and 0.05 ml of guinea pig 
or rabbit serum as a source of lyric C' for 45 min at 37°C. After incubation, the percentage of dead 
cells was determined by uptake of trypan blue dye. For each test, controls included incubating cells 
with  antiserum  alone  (serum  control)  or  C'  alone  (C'  control).  Incubations  were  in medium  199 
without serum supplements. 
Complement (C') for the cytotoxicity test.  Thymocytes were tested with either: (a) pooled rabbit 
serum from individual animals with low natural cytotoxicity for mouse lymphoid cells and high C' 
activity (21)  (rabbit  C'); or (b)  pooled guinea pig serum with low toxicity for mouse lymphoid cells 
and high C' activity (nontoxic guinea pig C'). RADA1 cells were tested with either: (a) pooled guinea 
pig serum toxic for normal mouse lymphoid cells but nontoxic for leukemia cells (toxic guinea pig C'); 
(b) rabbit C' absorbed with mouse lymphoid cells to decrease its natural toxicity for these cells and 
permit its use in higher concentrations on leukemia cells, absorption being done in the presence of 
EDTA to bind divalent cations and prevent loss of C' during absorption (21) (absorbed rabbit C'); or 
(c) nontoxic guinea pig C'. 
Immunofluorescence.  For indirect membrane fluorescence staining following modulation,  cells 
were fixed with 2% paraformaldehyde in phosphate-buffered saline, pH 7.4 (PBS), for 15 min at 0°C, 
washed  with PBS,  and  10 e cells were incubated  in 0.05  ml vols with rabbit  antimouse IgGfFITC 
antibody (100  #g/ml) or rabbit antimouse Fc fragments/FITC antibody (100  #g/ml)  in PBS for 30 
•  min  at  0°C.  Cells  were  washed,  resuspended  in  50%  glycerol  in  PBS,  and  examined  at  room 
temperature  with  a  Leitz  Orthoplan  microscope (E.  Leitz,  Wetzlar,  Germany)  equipped  with an 
Osram HBO 200W mercury lamp, and BG38 excitor, KP490 interference, and K530 barrier filters. For 
direct membrane fluorescence, cells were modulated with anti-ASL1/FTC antibody,  washed,  fixed 
with paraformaldehyde,  and examined in the same manner as indirect fluorescence. 
Immunoelectronmicroscopy.  The rabbit F(ab'}2 hybrid  antibody,  antimouse IgG/anti-southern 
bean mosaic virus (SBMV), and SBMV were prepared according to H~immerling et al. (22). Following 
modulation,  cells were fixed with  paraformaldehyde  as  described  above, then  5  ×  10  e cells were 
incubated in 0.1 mi of medium 199 containing 100 ttg/ml of hybrid antibody for 30 min at 0°C. After 
washing twice, the cells were incubated similarly with SBMV (100 #g/ml), washed,  and then fixed 
with 1% osmium tetroxide in 0.1 M  cacodylate buffer, pH 7.4.  Subsequent preparation for electron 
microscopy was as described previously (15). 
Results 
Characteristics  of Antigenic  Modulation In  Vitro.  Incubating  RADA1  cells 
with  anti-ASL1  (anti-TL.1,2,3)  antiserum  at  37°C  resulted  in  a  rapid  loss  of 
TL.  1,2,3  antigenicity  as  measured  by  the  cytotoxicity  test  using  toxic  guinea 
pig  serum  as  a  source  of  lytic  C'  (Fig.  1).  Loss  of  antigenicity  was  directly 
proportional  to the concentration  of antiserum  in the modulating  incubation,  and 
was  nearly  complete  within  1  h  when  dilutions  of 1/100  or less  were  used.  The 
initial cytotoxic titer (the dilution  at which  50% of the test cells are killed) of this 
antiserum  on RADA1  cells  using this  C'  was  1/5,000.  During  the  modulation  or 
preincubation,  and  in all subsequent  experiments,  cell viability remained  greater 
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substituted for TL antiserum. Since modulation of TL antigenicity was nearly as 
rapid and complete at an antiserum dilution of 1/100 as at 1/10,  in subsequent 
modulation experiments with RADA1 cells this antiserum was used at a dilution 
of 1/100.  By  contrast,  after  incubation of RADA1  cells  (H-2  ~  =  H-2  d~)  with 
anti-H-2  d antiserum for 4 h  under similar conditions, about 85% of the initial 
amount of H-2  a antigenicity remained demonstrable by cytotoxicity. 
Modulation of TL antigenicity from TL÷ thymocytes and RADA1 cells had 
similar characteristics,  except  that  thymocytes modulated considerably more 
slowly (Fig. 2). For comparison of modulation on these two cells, cytotoxicity  was 
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FI6.  1.  Effect  of TL  antiserum  dilution  on  modulation  of TL  antigenicity from  RADA1 
leukemia cells.  Cells were preincubated with dilutions of anti-ASL1 antiserum from 1/10 to 
1/1,000, or with a  1/10 dilution of normal mouse serum (NMS control), at 37°C, then residual 
TL  antigenicity  on  the  cell  surface  was  measured  by  cytotoxicity,  using fresh  anti-ASL1 
antiserum (diluted 1/100) and toxic guinea pig C' (diluted 1/3). Cells not preincubated were 
tested  by  cytotoxicity  directly.  Cell  viability  was  assessed  by  preincubating  cells  with 
antiserum (1/10), then testing the cytotoxicity of fresh antiserum (1/100) in the absence of C' 
(serum control). 
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FIG. 2.  Comparison of modulation of TL antigenicity from RADA1 cells and C57BL/6/TL  + 
thymocytes.  Both cell types  were  preincubated with anti-ASL1 antiserum (1/100)  at 37°C, 
then residual TL antigenicity was measured by cytotoxicity using fresh antiserum (1/100) and 
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measured  using  nontoxic  guinea  pig  C'.  The  cytotoxic  titer  of  anti-ASL1 
antiserum was about 1/3,000  on RADA1 cells and 1/5,000  on thymocytes using 
this C' source, indicating a  greater amount of TL antigenicity on thymocytes. 
While  modulation of RADA1  cells  was  about  50%  complete  after  20  min,  a 
comparable degree of modulation of thymocytes was reached only after 55 min. 
Modulation of TL  antigenicity from thymocytes, like  RADA1  cells,  occurred 
nearly as rapidly and completely at an antiserum dilution of 1/100 as at a dilution 
of 1/10. 
Immunofluorescence  of  Modulation.  The  fate  of  cell  surface-bound  TL 
antibody during modulation was visualized on RADA1 cells and thymocytes by 
immunofluorescence, using anti-ASL1/FTC antibody in the modulating preincu- 
bation. Since conjugation to FTC resulted in a decrease in the cytotoxic titer of 
anti-ASL1 antiserum on RADA1 cells to 1/40,  it was used at a dilution of 1/10. 
Following incubation for a  particular length of time, one  aliquot of cells  was 
examined  by  fluorescence  microscopy,  while  the  residual  TL  antigenicity of 
another aliquot of cells from the same sample was measured by cytotoxicity. 
Correlated immunofluorescence and cytotoxicity results are presented in Figs. 
3-6 and Fig. 9. After 15 min of preincubation, fluorescent label was distributed 
uniformly  over  the  entire  surface  of  all  cells,  but  was  also  concentrated 
immediately  beneath  the  cell  surface  at  several  locations,  presumably  in 
pinocytic vesicles  (Fig.  3).  Approximately 80%  of the  initial TL antigenicity 
remained on cells from this sample (Fig. 9). After 30 min, the cell surface was 
labeled uniformly except for occasional large aggregates, while considerable label 
had  been  internalized  in  cytoplasmic vesicles  (Fig.  4).  TL  antigenicity was 
reduced to about 60% of its initial level by this time (Fig. 9).  Label on the cell 
surface was completely aggregated into large "patches" after 1 h of preincubation 
(Fig. 5), with patches on 27% of the cells concentrated on one side of the cell into 
"caps" (10) (Fig. 9). Internalized label appeared to be concentrating within one 
region of the cell in many cases. Only 20% of the initial level of TL antigenicity 
remained on cells from this sample. By 2 h, with antigenicity reduced to 6% of its 
initial level, 70% of the cells displayed caps of label, with patches more generally 
distributed over the surfaces of the remainder of the cells (Figs. 6 and 9). Label 
inside the cells was usually concentrated in a region approximately opposite from 
the location of the capped surface label. The distribution of label on the surface 
and inside cells after 4 h of preincubation was similar to that at 2 h, caps having 
formed on nearly 90% of the cells (Fig. 9). 
Similar  results  were  obtained  when  RADA1  cells  were  modulated  with 
antithymus antiserum  (Fig.  9),  although  internalized antibody could  not  be 
visualized since this antibody was detected by indirect fluorescence staining with 
rabbit antimouse IgG/FITC antibody. Antithymus antiserum had a titer of 1/160 
on RADA1 cells using toxic guinea pig C', and was used at a dilution of 1/10 in the 
modulating incubation. Labeling patterns v~ere also similar inside and on the 
surfaces  of  thymocytes  modulated  with  anti-ASL1/FTC  antibody,  although 
patch and cap formation, like modulation, occurred more slowly than on RADA1 
cells. After 4 h, the labeling pattern, extent of capping, and degree of modulation 
on thymocytes was comparable to RADA1 cells after 2 h. 
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FIGS.  3-6.  Direct  immunofluorescence  of  modulation  of  TL  antigenicity  from  RADA1 
cells with anti-ASL1/FTC  antibody at  37°C.  ×  900.  Immunofluorescence and  cytotoxicity 
results from the same samples are presented in Fig. 9. 
Fro.  3.  Preincubated  for  15  min.  The  cell  surface  is  labeled  uniformly,  with  label  also 
concentrated at several locations immediately beneath the cell surface (arrows). 
Fro.  4.  Preincubated for 30 min. Label is distributed uniformly over the cell surface except 
for  occasional  large  aggregates  (long  arrow);  label  has  also  been  internalized  at  several 
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surfaces of RADA1 cells and thymocytes with bivalent antibody is accompanied 
by  progressive  displacement  of labeled  antibody  complexes  from  an  initially 
uniform  distribution  into  patches  and  ultimately  into  caps.  There  was  only a 
partial  loss of labeled  antibody from the  cell  surface  into pinocytic vesicles. It 
appears that modulation precedes cap formation, but it is important to note that 
the  fluorescence  microscopy observations were made immediately following the 
preincubation,  while  the  amount  of antigenicity  remaining  on other  cells from 
the  same samples was determined  during  a  subsequent  cytotoxicity incubation 
lasting  45  min.  Although  it  is likely that  cytolysis is initiated  shortly after the 
addition  of fresh  antiserum  and  C',  further  topographical  displacement  of TL 
antigen-antibody  complexes  may  have  occurred  during  this  incubation  which 
could  influence  the  amount  of TL  antigenicity  detectable  on  the  ceil  surface. 
Therefore,  on the basis of these observations, it is difficult to precisely correlate 
modulation of TL antigenicity with surface distribution  of TL antigen-antibody 
complexes. 
In order to clarify this relationship, we examined the fate of monovalent Fab' 
fragments of anti-ASL1 antibody used to modulate TL antigenicity from RADA1 
cells, since these fragments have modulating capabilities comparable to bivalent 
antibody  (16).  Direct  fluoresceination  of Fab'  fragments  was  not  feasible,  so 
indirect  fluorescence  staining  was  employed.  Following  modulation  with  Fab' 
fragments for a particular length of time, one aliquot of cells was fixed, incubated 
with  rabbit  antimouse IgG/FITC antibody,  and then examined by fluorescence 
microscopy.  The  amount  of TL  antigenicity  remaining on the  cell surface was 
determined  by cytotoxicity  on  another  aliquot  of cells  from the  same  sample. 
Preparations  of Fab'  fragments  of anti-ASL1  antiserum  used  in  these  experi- 
ments lacked the C'-binding Fc antibody fragment, as indicated by the complete 
lack  of  visible  fluorescence  staining  when  RADA1  cells  incubated  with  Fab' 
fragments  were  subsequently  incubated  with  fluorescent  rabbit  antimouse  Fc 
fragments/FITC antibody. 
After  modulating  RADA1  cells  for  30  min  with  Fab'  fragments,  indirect 
labeling demonstrated  a  uniform distribution  of these fragments over the entire 
cell surface (Fig. 7), while the TL antigenicity of these cells was reduced to about 
50%  of the  initial  level (Fig.  9).  Uniform surface labeling was also observed on 
about 90% of the cells after I h of preincubation, with label on the remaining 10% 
of  the  cells  appearing  slightly  aggregated.  Less  than  20%  of  the  initial  TL 
Fro. 5.  Preincubated  for  1 h.  Label  on  the  cell surface  is  completely  aggregated  into 
"patches," while internalized label has begun to coalesce into one region of the cell {arrows). 
Fro. 6.  Preincubated for 2 h. Patches of label have concentrated  into "caps" over one pole of 
the cell, with internalized  label coalesced within the opposite pole of the cell in most cases 
(short arrows). The cap on one cell and internalized label within the opposite pole of the cell 
are visualized end-on (long arrow). 
FIGs. 7-8.  Indirect  immunofluorescence of modulation of TL antigenicity from RADA1 cells 
with Fab' fragments of anti-ASL1 antibody at 37 °C. Antibody fragments were detected, after 
fixing the cells, by incubating  with rabbit antimouse IgG/FITC antibody.  × 1,200. Immuno- 
fluorescence and cytotoxicity results on the same samples are presented in Fig. 9. 
FIG. 7.  Preincubated for 30 min. Label is distributed  uniformly over the entire cell surface. 
FIG. 8.  Preincubated  for  2  h.  Numerous  aggregates  of label  are  distributed  over  the 
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antigenicity remained after 1 h.  Only about 10% of the initial TL antigenicity 
remained on the surfaces of cells preincubated with Fab' fragments for 2 h. By 
this  time,  surface  fluorescence on  about  80%  of the  cells  appeared  as  small 
aggregates of label  distributed over the  entire cell  surface  (Fig.  8),  while the 
surfaces of the  remainder of the  cells  were  uniformly labeled.  Only 2%  of all 
labeled cells  displayed cap formation (Fig. 9).  Internalized label could not be 
visualized by this indirect staining procedure. 
These results indicate that modulation of TL antigenicity precedes, and is not 
dependent upon, redistribution of cell surface-bound TL antibody into patches or 
caps,  since  such  gross  redistribution  was  not  induced  by  Fab'  antibody 
fragments. However, as in modulation with bivalent anti-ASL1/FTC antibody, 
residual TL antigenicity was measured during a 45-min cytotoxicity incubation 
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FIG. 9.  Residual TL  antigenicity and extent of cap formation on RADA1  cells modulated 
with  bivalent  and  monovalent  TL  antibody.  (A)  Cells  modulated  with  anti-ASL1/FTC 
antibody  (1/10)  or  antithymus  antiserum  (1/10)  at  37°C.  Results  for  modulation  with 
anti-ASL1/FTC  antibody are  from the same samples from which the immunofluorescence 
micrographs  in  Figs.  3-6  were  obtained.  Cytotoxicity  was  measured  using  anti-ASL1 
antiserum (1/100) or antithymus antiserum (1/10) and toxic guinea pig C' (1/3). Cap formation 
on  cells  modulated  with  antithymus  antiserum  was  determined  by  fixing  the  cells  and 
incubating with rabbit antimouse IgG/FITC antibody. (B)  Cells modulated with monovalent 
Fab' fragments of anti-ASL1 antibody (80/~g/ml) at 37°C. Data was obtained from the same 
samples from which the immunofluorescence  micrographs in Figs. 7  8 were taken. Cytotoxicity 
was measured with anti-ASL1 antiserum (1/10)  and toxic guinea pig C' (1/3).  Cap formation 
was determined on cells fixed and then incubated with rabbit antimouse IgG/FITC antibody. C.  W.  STACKPOLE,  J.  B.  JACOBSON,  AND M.  P.  LARDIS  947 
following the modulating incubation, although fluorescence microscopy observa- 
tions  were  based  on  cells  preincubated  only.  Therefore,  since  some  further 
displacement of cell-bound Fab' antibody fragments might have occurred before 
cytolysis was initiated,  a  redistribution  of TL antigen-antibody  complexes into 
visible aggregates on the cell surface may be directly involved in modulation of 
TL anti~enicity. 
Immunoelectronmicroscopy  of Modulation.  To  determine  the  site  of  cap 
formation  on  modulated  cells,  RADA1  cells  were  modulated  for  2  h,  and 
thymocytes for  4  h,  with  anti-ASL1/FTC  antiserum  as  described  above,  and 
fixed. One aliquot of cells was examined by fluorescence microscopy, and label on 
the cell surface and within the cells appeared as in Fig. 6. Another aliquot of cells 
was  incubated  sequentially  with  hybrid  antimouse  IgG/anti-SBMV  antibody 
and  SBMV,  and then  prepared  for electron  microscopy. On both RADA1 cells 
and thymocytes, 70-80% of the caps of label observed in sections in which the 
Golgi region of the cell was evident were formed over the pole of the cell opposite 
from the Golgi region (Fig. 10), none were directly over the Golgi region, and the 
remainder occupied intermediate positions. Label observed to be internalized by 
cells modulated with anti-ASL1/FTC  antibody must, therefore, become seques- 
tered into the Golgi region of the cell, since it is usually apparent within the cell 
in  a  position directly opposite from the caps of external  label  (Fig.  6).  Similar 
results were obtained using antithymus  antiserum  for modulation,  although  in 
this case cells were not prepared for fluorescence microscopy. 
Effect of Complement (C')  on Modulation.  The cytotoxic titer of anti-ASL1 
antiserum  on  RADA1  cells was considerably  higher  (1/10,000)  when  absorbed 
rabbit serum was used as a source of lytic C' than when toxic guinea pig C' was 
used  (1/5,000).  Because  of  this  greater  sensitivity,  we  tested  residual  TL 
antigenicity  using  absorbed  rabbit  C'  following  modulation.  When  absorbed 
rabbit C' was substituted for toxic guinea pig C' in the cytotoxicity test, the loss 
of TL  antigenicity  from  RADA1  cells  during  a  modulating  incubation  with 
anti-ASL1 antiserum was considerably reduced (Fig. 11). After 4 h of incubation, 
only 21% of the initial  TL antigenicity was lost when cytotoxicity was assessed 
using absorbed rabbit C', compared to a 95% loss when toxic guinea pig C' was 
used. 
This would seem to indicate that following modulation nearly 80% of the initial 
quantity of TL antigens  remains  on the cell surface,  unless absorbed rabbit  C' 
operates by an unusual mechanism which does not require direct interaction with 
cell surface-bound antigen-antibody  complexes. In order to test this possibility, 
we attempted to prevent the cytolytic activity of absorbed rabbit C' by covering 
cell-bound  TL  antibody  with  a  secondary  rabbit  antimouse  IgG  antibody. 
Bivalent F(ab')2 antibody fragments lacking the C'-binding Fc portion were used 
to  avoid  cytolytic  interaction  of  absorbed  rabbit  C'  with  these  antibody 
molecules. Incubating cells with these F(ab')2 fragments for I h at 37°C following 
modulation  for  1 h  resulted  in  a  complete loss of the residual  TL antigenicity 
indicated  by  cytotoxicity  with  absorbed  rabbit  C'  (Fig.  11).  Cytolysis  by 
absorbed  rabbit  C'  must  therefore  depend  upon  direct  interaction  with  cell 
surface-bound antigen-antibody complexes. 
In  contrast,  incubating  RADA1  cells  under  modulating  conditions  with 948  ANTIGENIC MODULATION IN VITRO 
FIG.  10.  Electron  micrograph of a  RADA1  cell  modulated with anti-ASL1/FTC antibody 
(1/10)  for  2  h  at  37°C,  fixed,  and  then  incubated  sequentially  with  hybrid  antimouse 
IgG/anti-SBMV antibody and SBMV at 0°C. Label is confined to a "cap" (bracket) over the 
pole of the cell opposite from the Golgi region (G).  ×  16,000. 
anti-ASL1 antiserum which had been heated at 56°C for I h significantly reduced 
the usual loss of TL antigenicity as measured by cytotoxicity using toxic guinea 
pig C'  (Table I). Modulating capacity was restored to this heated antiserum by 
adding  either  NMS  or  hyperimmune  mouse  antiserum  directed  against  cell 
surface antigens  (H-2  ~ antigens)  not detectable on RADA1  cells. A  heat-labile 
factor present in TL antiserum and mouse serum in general is therefore essential 
for the demonstration of modulation with guinea pig C'. c.  w.  STACKPOLE,  J.  B.  JACOBSON,  AND M.  P.  LARDIS  949 
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Fro.  11.  Residual  TL  antigenicity on  RADA1  cells  modulated with  anti-ASL1  antiserum 
(1/100), as measured by cytotoxicity using different sources of lytic C'. Following modulation, 
cell surface TL  antigenicity was tested with anti-ASL1  antiserum  (1/100)  and either toxic 
guinea pig C' (1/3) or absorbed rabbit C' (1/4). After 1 h of modulation at 37 °C, samples of cells 
were washed twice and incubated with 100 pg/ml of F(ab')~ fragments of rabbit antimouse IgG 
antibody [F(ab')2 anti-IgG] at 37°C for 1 and 2 h, after which cytotoxicity was measured using 
absorbed rabbit C'. 
TABLE  I 
Effect of Heating TL Antiserum on Modulation  of TL Antigenic- 
ity from RADA1  Leukemia  Cells 
Cytotoxicity tests 
Modulating serum*  (% cells killed) 
None  92 
Anti-ASL1 antiserum  8 
Anti-ASL1 antiserum, heated§  68 
NMS  94 
Anti-ASL1 antiserum, heated +  NMS  12 
Anti-H-2  b antiserum II  90 
Anti-ASL1 antiserum, heated +  anti-H-2' antiserum  8 
* Cells were incubated for 1 h  at 37°C,  with serum, when added,  diluted 
1/100. 
$ After the  modulating incubation, cells were washed and incubated for 
45 min at 37°C with fresh anti-ASL1 antiserum (1/100) and toxic guinea 
pig C' (1/3); killed cells were distinguished by uptake of trypan blue dye. 
§56°C  for  1 h;  after heating,  this antiserum retained  its  full  cytotoxic 
titer on RADA1 ceils (1/5,000) when tested using toxic guinea pig C'. 
II This  antiserum  (H-2 ~'  vs.  H-2  ~)  has no  cytotoxic  activity  on  RADA1 
(H-2 ~') cells. 
Discussion 
Our  results  indicate  that  in vitro modulation  of TL  antigenicity  from the surfaces 
of RADA1  leukemia  cells  and  normal  thymocytes  does  not  involve  an  extensive 
loss  of  TL  antigen-antibody  complexes  from  the  cell  surface,  as  has  been 950  ANTIGENIC  MODULATION  IN VITRO 
postulated (6, 7), and moreover is demonstrable by C'-mediated cytotoxicity only 
under certain conditions. 
Modulation of TL antigenicity with bivalent antibody, indicated by a toss of 
cytotoxic  sensitivity  to  lytic  guinea  pig  C',  was  accompanied  initially  by  a 
significant  amount  of  pinocytosis,  which  decreased  as  antibody  complexes 
remaining  on the  cell surface became progressively displaced into patches and 
caps. Cap formation usually occurred over the pole of the cell opposite from the 
Golgi region. Analysis of capping on mouse lymphoid cells has shown that surface 
receptors on splenic lymphocytes generally cap over the Golgi region, accompa- 
nied  by extensive  pinocytosis,  while  receptors  on  thymocytes  most  often  cap 
opposite from the Golgi region, with little pinocytosis occurring (23). It is evident 
that capping is not directly related to modulation,  but since the Golgi region is 
apparently the portion of the cell most active in pinocytosis, mobilization of TL 
antigen-antibody complexes away from this region of the cell during modulation 
may in part account for the retention of modulated complexes on the cell surface. 
Modulation  with monovalent  Fab' antibody fragments was nearly completed 
before any  aggregation  of TL  antigen-antibody  complexes  on  the  cell  surface 
became apparent.  Although the extent of pinocytosis occurring during modula- 
tion  with  Fab'  fragments  could  not  be  determined  directly,  these  antibody 
fragments remained readily detectable on the cell surface following modulation, 
indicating that pinocytosis could not have been extensive. Since pinocytosis may 
require  ligand-induced  aggregation  of receptors  on  the  cell  surface  (24),  Fab' 
antibody fragments may not induce sufficient aggregation to stimulate pinocyto- 
sis, at least until  after modulation  is completed. 
The continued  cytotoxic sensitivity of RADA1 cells to  (a)  TL antiserum  and 
absorbed rabbit C' after a  standard  modulation  incubation with TL antiserum, 
and  (b)  TL  antiserum  and  toxic  guinea  pig  C'  following  preincubation  with 
heated TL antiserum provides further evidence that a considerable number of TL 
antigen-antibody complexes remain bound to the cell surface following modula- 
tion in vitro. The observed loss of about 20% of the initial level of TL antigenicity 
on  RADA1  cells  after  several  hours  of preincubation  with  TL  antiserum  may 
represent  the  approximate  percentage  of TL  antigen-antibody  complexes  ac- 
tually  lost  from  the  cell  surface  either  by pinocytosis or  exfoliation  into  the 
extracellular environment,  or by a combination of these processes. 
The fate of TL antigen-antibody complexes during modulation of TL antige- 
nicity from the surfaces of ASL1 leukemia cells has recently been examined by 
Yu and Cohen  (7)  by isolating solubilized cell surface TL antigens by immuno- 
precipitation.  Modulation  of ASL1  cells,  measured  by the cytolytic effect of a 
subsequent  exposure  to  fresh  TL  antiserum  and  guinea  pig  C',  occurred  very 
slowly by comparison  with  modulation  rates we observed for RADA1 cells and 
thymocytes,  modulation  being  completed  only  after  10-15  h  of preincubation 
with  TL  antiserum.  Although  the  rate  of  intracellular  synthesis  of new  TL 
antigens  remained  essentially the  same  in  cells undergoing  modulation  and  in 
unmodulated cells, the recovery of TL antigens from the surfaces of modulating 
cells  diminished  gradually  compared  with  unmodulated  cells,  loss  of antigen 
becoming apparent  initially after 12 h of incubation. Pinocytosis was implicated 
in  this  observed  loss  of TL  antigens,  since  the  extent  of exfoliation  into  the C.  W.  STACKPOLE,  J.  B.  JACOBSON,  AND  M.  P.  LARDIS  951 
extracellular  environment  was  no  greater  from  modulating  cells  than  from 
unmodulated cells,  and there was no evidence for localized degradation of cell 
surface-bound antigens (7). 
It is difficult to correlate our results with those of Yu and Cohen (7) for several 
reasons:  (a)  since  their  modulating  TL  antiserum  also  contained  non-TL 
antibodies, they were unable to determine by immunofluorescence whether TL 
antibody remained  cell-bound following modulation;  and  (b)  in  their  experi- 
ments cells were modulated with antiserum which had previously been heated at 
56°C for 30 min, a procedure which we found to suppress modulation, and which 
may explain why modulation occurred so slowly. 
While our results indicate that some TL antigens remain on the surfaces of 
cells modulated in vitro with TL antibody, modulation of other surface receptors, 
such as surface Ig on mouse lymphoid cells (8), may involve a more complete loss 
from the cell surface, since surface receptors cap in different locations on the cell 
surface and are thus differentially susceptible to pinocytosis (23).  It will also be 
interesting to determine whether TL antigens remain on  the surfaces of cells 
modulated in vivo (1). 
The interaction of modulating TL antibody, or antibody fragments, with TL 
antigens on the cell surface resulted in a  topographical displacement of these 
antigens,  although modulation preceded extensive redistribution into patches 
and caps. A more subtle alteration in the organization of molecules bearing TL 
antigenic determinants within the cell surface membrane, or in the topographical 
interrelationships between these molecules, which would precede visible redistri- 
bution, may be more directly involved in "blocking" of guinea pig C'-mediated 
cytolysis. On thymocytes, TL antigens are much more readily capped than H-2 
antigens (25).  This difference in the tendency for these antigens to be displaced 
topographically as a  result of specific antibody binding may be correlated with 
their tendency to modulate, since H-2 antigens are modulated very poorly with 
H-2 antibody alone, but  much more readily when an antimouse Ig antibody is 
added (8, 9). Another indication that some type of redistribution may be involved 
in  modulation  is  the  difference  in  the  rates  at  which  TL  antigenicity was 
modulated from RADA1 cells and thymocytes under the same conditions. By the 
criterion of cytotoxicity sensitivity, there appears to be a greater quantity of TL 
antigens on thymocytes than on RADA1 cells. An inverse relationship between 
the quantity of a particular receptor on the cell surface and the rate and extent of 
redistribution into caps  has been observed with normal mouse lymphoid cells 
(25). The tendency for TL antigens to modulate may also be partially related to 
the amount of antigen on the cell surface. 
Further elucidation of the mechanisms involved in in vitro modulation of TL 
antigenicity may  explain  why TL  antigens  appear  to  be  unique  among  cell 
surface antigens in this regard, and may contribute to our understanding of the 
organization of the cell surface. 
Summary 
The modulation or loss of thymus-leukemia (TL) antigenicity from the surfaces 
of mouse RADA1 leukemia cells and normal thymocytes during incubation with 952  ANTIGENIC  MODULATION IN  VITRO 
TL antibody  in vitro at 37°C  was investigated by cytotoxicity, immunofluores- 
cence,  and  immunoelectronmicroscopy.  The  fate  of bivalent  and  monovalent 
antibody during modulation was visualized by fluorescence microscopy. Consid- 
erable antibody remained  bound  to the  cell surface  after modulation,  bivalent 
antibody  being  displaced  topographically  into  "patches"  and  "caps"  while 
monovalent  antibody  was  only  slightly  aggregated  on  the  cell  surface.  Some 
antibody was internalized,  presumably by pinocytosis, and was sequestered into 
the  Golgi region  of the  cell.  Capping  usually occurred  over the  pole of the  cell 
opposite  from  the  Golgi  region,  which  may  explain  the  lack  of  extensive 
pinocytosis of modulating bivalent antibody. Since modulation with monovalent 
antibody occurs without patch or cap formation,  gross topographical redistribu- 
tion of TL antigen-antibody complexes is not required for modulation, although 
more subtle displacement of these complexes may be involved. 
Modulation  was demonstrable by cytotoxicity with guinea pig C' but not with 
absorbed rabbit C', indicating that modulated TL antigens remain bound to the 
cell surface. A heat-labile factor in TL antiserum and in mouse serum in general 
is  responsible  for  "blocking"  the  cytolytic  interaction  of  guinea  pig  C'  with 
modulated TL antigen-antibody  complexes. 
We thank Dr. E. A. Boyse and Miss Chika Iritani for providing antisera,  and Dr. M. E. Lamm for 
preparing Fab' antibody fragments, for these experiments. The valuable advice of Dr. Boyse, Dr. L. J. 
Old, and Dr. Elisabeth  Stockert  is gratefully acknowledged. 
Received for publication 10 June 1974. 
References 
1.  Boyse,  E.  A.,  L.  J.  Old,  and  S.  Luell.  1963. Antigenic  properties of experimental 
leukemias.  II.  Immunological  studies  in  vivo  with  C57BL/6  radiation-induced 
leukemias. J. Natl.  Cancer Inst. 31:987. 
2.  Boyse, E. A., L. J. Old, and E. Stockert. 1965. The TL (thymus leukemia) antigen: a 
review.  In Immunopathology, IVth International  Symposium. P.  Grabar and P.  A. 
Miescher, editors. Schwabe & Co., Basel. 23. 
3.  Boyse, E. A., E. Stockert, and L. J. Old. 1969. Properties of' four antigens specified by 
the Tla locus. Similarities and differences. In International Convocation on Immunol- 
ogy. N. R. Rose and F. Milgrom, editors.  S. Karger, AG, Basel. 353. 
4.  Boyse,  E.  A.,  and  L.  J.  Old.  1971. A  comment  on  the  genetic  data  relating  to 
expression of TL antigens.  Transplantation.  11:561. 
5.  Boyse, E. A., E. Stockert, and L. J. Old. 1967. Modification of the antigenic structure 
of the  cell  membrane  by thymus-leukemia  (TL)  antibody.  Proc.  Natl.  Acad.  Sci. 
U.S.A. 58:954. 
6.  Old, L. J., E. Stockert, E. A. Boyse, and J. H. Kim. 1968. Antigenic modulation. Loss 
of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J. 
Exp. Med.  127:523. 
7.  Yu,  A.,  and  E.  P.  Cohen.  1974. Studies  on  the  effect of' specific antisera  on  the 
metabolism of cellular antigens. II. The synthesis and degradation of' TL antigens of 
mouse cells in the presence of TL antiserum. J. Immunol.  112:1296. 
8.  Takahashi, T. 1971. Possible examples of antigenic modulation affecting H-2 antigens 
and cell surface immunoglobulins.  Transplant. Proc. 3:1217. C.  W. STACKPOLE, J.  B. JACOBSON, AND M. P. LARDIS  953 
9.  Lengerov~, A., Z. Pokorn~, V. Viklick), and V. Zelen:~. 1972. Phenotypic suppression 
of H-2 antigens and topography of the cell surface.  Tissue Antigens. 2:332. 
10.  Taylor, R.  B.,  P.  H. Duffus,  M.  C. Raft,  and  S.  de Petris.  1971. Redistribution and 
pinocytosis  of  lymphocyte  surface  immunoglobulin  molecules  induced  by  anti- 
immunoglobulin antibody. Nat. New Biol. 223:225. 
11.  Yu,  A.,  and  E.  P.  Cohen.  1974. Studies  on  the  effect of specific  antisera  on the 
metabolism of cellular antigens. I. Isolation of thymus leukemia antigens. J. Immunol. 
112:1285. 
12.  Boyse,  E.  A.,  E.  Bressler,  C.  A.  Iritani,  and  M.  Lardis.  1970. Cytotoxic  ~M 
autoantibody in mouse alloantisera.  Transplantation. 9:339. 
13.  Boyse,  E.  A.,  L.  Flaherty,  E.  Stockert,  and  L.  J.  Old.  1972. Histoincompatibility 
attributable  to  genes  near  H-2  that  are  not  revealed  by  hemagglutination  or 
cytotoxicity tests.  Transplantation.  13:431. 
14.  H~immerling,  U.,  and  K.  Rajewsky.  1971. Evidence for surface-associated immuno- 
globulin on T  and B lymphocytes. Eur. J. Immunol.  1:447. 
15.  H~mmerling,  U.,  C.  W.  Stackpole:  and  G.  C.  Koo.  1973. Hybrid  antibodies  for 
labeling  cell  surface  antigens.  In Methods  in  Cancer  Research,  Vol.  9.  H.  Busch, 
editor. Academic Press, Inc. New York. 225. 
16.  Lamm, M. E., E. A. Boyse, L. J. Old,  B. Lisowska-Bernstein, and E. Stockert. 1968. 
Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody. J. 
Immunol.  101:99. 
17.  Cebra,  J.  J.,  and  G.  Goldstein.  1965. Chromatographic purification of tetramethyl- 
rhodamine-immune  globulin  conjugates and  their use in  the cellular localization of 
rabbit ~-globulin polypeptide chains. J. ImmunoI. 95:230. 
18.  H~mmerling, U., A. F. Chin,  and M. Arny. 1974. Fluorescence labeling of mouse allo- 
antibodies. Eur. J. Immunol. 4:314. 
19.  Gorer, P. A., and P. O'Gorman. 1956. The cytotoxic activity of isoantibodies in mice. 
Transplant. Bull. 3:142. 
20.  Boyse, E. A., L. J. Old, and I. Chouroulinkov. 1964. Cytotoxic test for demonstration 
of mouse antibody. In Methods in Medical Research. Year Book Medical Publishers, 
Inc., Chicago. 10:39. 
21.  Boyse,  E.  A.,  L.  Hubbard,  E.  Stockert,  and  M.  E.  Lamm.  1970. Improved 
complementation in the cytotoxic test.  Transplantation.  10:446. 
22.  H~mmerling, U., T. Aoki, H. A. Wood, L. J. Old, E. A. Boyse, and E. de Harven. 1969. 
New visual markers of antibody for electron microscopy. Nature (Lond.). 223:1158, 
23.  Stackpole,  C.  W.,  J.  B.  Jacobson,  and  M.  P.  Lardis.  1974. Two distinct  types of 
capping of surface receptors on mouse lymphoid cells.  Nature (Lond.). 248:232. 
24.  Gingell,  D.  1973. Membrane permeability change by aggregation of mobile glycopro- 
tein units. J.  Theor. Biol. 38:677. 
25.  Stackpole, C. W., L. T. De Milio,  J. B. Jacobson, U. H~mmerling, and M. P. Lardis. 
1974.  A  comparison  of' ligand-induced  redistribution  of surface  immunoglobulins, 
alloantigens, and concanavalin A receptors on mouse lymphoid cells. J. Cell. Physiol. 
83:441. 